Pacer Advisors, Inc. Illumina, Inc. Transaction History

Pacer Advisors, Inc.

$41.8 Billion
Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 31,193 shares of ILMN stock, worth $4.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

31,193

Previous 31,762 1.79%

Holding current value

$4.08 Million

Previous $3.32 Million 22.68%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$105.28 - $135.9 $59,904 - $77,327	-569 Reduced 1.79%	31,193 $4.07 Million
Q2 2024 Aug 13, 2024	BUY	$101.05 - $133.57 $1.34 Million - $1.78 Million	13,290 Added 71.95%	31,762 $3.32 Million
Q1 2024 May 10, 2024	SELL	$127.73 - $147.2 $197,087 - $227,129	-1,543 Reduced 7.71%	18,472 $2.54 Million
Q4 2023 Jan 16, 2024	SELL	$92.79 - $142.53 $3.54 Million - $5.44 Million	-38,168 Reduced 65.6%	20,015 $2.79 Million
Q3 2023 Nov 13, 2023	BUY	$128.91 - $192.44 $755,154 - $1.13 Million	5,858 Added 11.2%	58,183 $7.99 Million
Q2 2023 Jul 12, 2023	SELL	$183.43 - $232.67 $3.06 Million - $3.88 Million	-16,693 Reduced 24.19%	52,325 $9.81 Million
Q1 2023 May 02, 2023	BUY	$193.75 - $232.55 $12.4 Million - $14.8 Million	63,758 Added 1212.13%	69,018 $16.1 Million
Q4 2022 Feb 06, 2023	SELL	$187.24 - $242.74 $9.56 Million - $12.4 Million	-51,077 Reduced 90.66%	5,260 $1.06 Million
Q3 2022 Oct 18, 2022	BUY	$177.23 - $227.44 $8.59 Million - $11 Million	48,476 Added 616.66%	56,337 $10.7 Million
Q2 2022 Aug 12, 2022	SELL	$181.58 - $368.0 $3 Million - $6.08 Million	-16,514 Reduced 67.75%	7,861 $1.45 Million
Q1 2022 Apr 05, 2022	BUY	$303.87 - $423.8 $2.84 Million - $3.96 Million	9,352 Added 62.25%	24,375 $8.52 Million
Q4 2021 Feb 03, 2022	BUY	$347.28 - $421.83 $283,727 - $344,635	817 Added 5.75%	15,023 $5.72 Million
Q3 2021 Oct 15, 2021	BUY	$405.61 - $524.84 $155,348 - $201,013	383 Added 2.77%	14,206 $5.76 Million
Q2 2021 Jul 21, 2021	BUY	$372.84 - $481.5 $239,736 - $309,604	643 Added 4.88%	13,823 $6.54 Million
Q1 2021 Apr 05, 2021	SELL	$361.28 - $504.76 $502,540 - $702,121	-1,391 Reduced 9.55%	13,180 $5.06 Million
Q4 2020 Jan 20, 2021	SELL	$292.7 - $370.96 $2.26 Million - $2.86 Million	-7,715 Reduced 34.62%	14,571 $5.39 Million
Q3 2020 Oct 19, 2020	SELL	$268.51 - $400.74 $906,489 - $1.35 Million	-3,376 Reduced 13.16%	22,286 $6.89 Million
Q2 2020 Jul 29, 2020	BUY	$256.46 - $373.01 $3.52 Million - $5.12 Million	13,733 Added 115.12%	25,662 $9.5 Million
Q1 2020 Apr 23, 2020	BUY	$209.2 - $335.53 $73,220 - $117,435	350 Added 3.02%	11,929 $3.77 Million
Q4 2019 Feb 10, 2020	SELL	$288.29 - $335.49 $4.28 Million - $4.98 Million	-14,845 Reduced 56.18%	11,579 $3.84 Million
Q3 2019 Oct 10, 2019	BUY	$266.84 - $378.23 $722,069 - $1.02 Million	2,706 Added 11.41%	26,424 $8.04 Million
Q2 2019 Aug 12, 2019	BUY	$300.59 - $368.15 $714,803 - $875,460	2,378 Added 11.14%	23,718 $8.73 Million
Q1 2019 Apr 10, 2019	BUY	$272.57 - $321.18 $5.82 Million - $6.85 Million	21,340 New	21,340 $6.63 Million
Q4 2018 Feb 13, 2019	SELL	$272.46 - $366.54 $3.7 Million - $4.98 Million	-13,597 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$279.04 - $367.06 $583,751 - $767,889	2,092 Added 18.18%	13,597 $4.99 Million
Q2 2018 Aug 14, 2018	BUY	$228.17 - $292.07 $465,238 - $595,530	2,039 Added 21.54%	11,505 $3.21 Million
Q1 2018 May 14, 2018	BUY	$209.54 - $253.91 $348,884 - $422,760	1,665 Added 21.34%	9,466 $2.24 Million
Q4 2017 Feb 14, 2018	BUY	$202.23 - $230.03 $586,264 - $666,856	2,899 Added 59.14%	7,801 $1.7 Million
Q3 2017 Nov 08, 2017	BUY	$172.3 - $213.93 $844,614 - $1.05 Million	4,902	4,902 $976,000

Others Institutions Holding ILMN

# of Institutions

901

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $20.6B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Illumina, Inc. Transaction History